JAK2 V617F和CALR突变并非相互排斥；来自一个小患者队列的回顾性分析结果。 - Suppr

Suppr

超能文献

JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort.

作者信息

McGaffin Gillian, Harper Kirsteen, Stirling David, McLintock Lorna

机构信息

Department of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK.

出版信息

Br J Haematol. 2014 Oct;167(2):276-8. doi: 10.1111/bjh.12969. Epub 2014 Jun 17.

DOI:10.1111/bjh.12969

PMID:24935260

Abstract

摘要

相似文献

JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort.JAK2 V617F和CALR突变并非相互排斥；来自一个小患者队列的回顾性分析结果。

Br J Haematol. 2014 Oct;167(2):276-8. doi: 10.1111/bjh.12969. Epub 2014 Jun 17.

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.伴有CALR或JAK2突变的原发性血小板增多症的表型与预后分析。

Haematologica. 2015 Jul;100(7):893-7. doi: 10.3324/haematol.2014.118299. Epub 2015 May 1.

Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.真性红细胞增多症患者中JAK2和CALR突变的共存及其临床意义。

Oncotarget. 2016 Aug 30;7(35):57036-57049. doi: 10.18632/oncotarget.10958.

Skewed ratio between type 1 and type 2 calreticulin mutations in essential thrombocytosis patients with concomitant Janus kinase 2 V617F mutation.伴有Janus激酶2 V617F突变的原发性血小板增多症患者中1型和2型钙网蛋白突变之间的比例失衡。

Exp Hematol. 2018 Dec;68:62-65. doi: 10.1016/j.exphem.2018.09.007. Epub 2018 Oct 4.

Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia.低等位基因负担JAK2 V617F原发性血小板增多症中CALR和MPL突变的检测

J Mol Diagn. 2017 Jan;19(1):92-98. doi: 10.1016/j.jmoldx.2016.08.006. Epub 2016 Nov 14.

Somatic mutations of calreticulin in myeloproliferative neoplasms.髓系增殖性肿瘤中的钙网织蛋白体细胞突变。

N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10.

Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2 mutations and laboratory findings: a meta-analysis.通过评估CALR和JAK2突变及实验室检查结果对原发性血小板增多症的诊断和预后进行评估：一项荟萃分析

Clin Transl Oncol. 2017 Jul;19(7):874-883. doi: 10.1007/s12094-017-1618-1. Epub 2017 Feb 15.

JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis.韩国原发性血小板增多症和原发性骨髓纤维化患者的JAK2 V617F、MPL及CALR突变

J Korean Med Sci. 2015 Jul;30(7):882-8. doi: 10.3346/jkms.2015.30.7.882. Epub 2015 Jun 10.

CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.四种不同亚型骨髓增殖性肿瘤患者（原发性骨髓纤维化、原发性血小板增多症、真性红细胞增多症和无法分类的骨髓增殖性肿瘤）的CALR、JAK2和MPL突变谱

Am J Clin Pathol. 2015 May;143(5):635-44. doi: 10.1309/AJCPUAAC16LIWZMM.

CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms.CALR 突变在一组怀疑患有骨髓增殖性肿瘤但 JAK2 V617F 阴性的患者中。

Sci Rep. 2019 Dec 27;9(1):19838. doi: 10.1038/s41598-019-56236-x.

引用本文的文献

Prediction of acute coronary syndrome in patients with myeloproliferative neoplasms.骨髓增殖性肿瘤患者急性冠状动脉综合征的预测

Front Cardiovasc Med. 2024 Jun 25;11:1369701. doi: 10.3389/fcvm.2024.1369701. eCollection 2024.

Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR.具有JAK2、MPL或CALR非典型变异的Ph阴性骨髓增殖性肿瘤患者的临床实验室特征及基因突变谱

Cancer Med. 2024 Apr;13(7):e7123. doi: 10.1002/cam4.7123.

JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.哥伦比亚BCR-ABL阴性骨髓增殖性肿瘤患者的JAK2、CALR和MPL突变谱

Colomb Med (Cali). 2023 Sep 30;54(3):e2035353. doi: 10.25100/cm.v54i3.5353. eCollection 2023 Jul-Sep.

Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in , and .携带、和同时突变的费城阴性骨髓增殖性肿瘤患者的遗传和临床特征。

Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231154092. doi: 10.1177/15330338231154092.

A Rare Co-Occurrence of Triple Mutations in , and in the Same Patient with Myelofibrosis.一名骨髓纤维化患者中，[具体基因名称未给出]、[具体基因名称未给出]和[具体基因名称未给出]同时发生三重突变的罕见病例。

Case Rep Hematol. 2022 Feb 21;2022:4579122. doi: 10.1155/2022/4579122. eCollection 2022.

Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing.骨髓增殖性肿瘤的遗传图谱，重点关注分子诊断实验室检测

Life (Basel). 2021 Oct 30;11(11):1158. doi: 10.3390/life11111158.

Primary myelofibrosis with concurrent and mutations: A case report.原发性骨髓纤维化合并[具体突变]：一例报告

World J Clin Cases. 2020 Nov 26;8(22):5618-5624. doi: 10.12998/wjcc.v8.i22.5618.

Mutant Calreticulin in the Myeloproliferative Neoplasms.骨髓增殖性肿瘤中的突变型钙网蛋白

Hemasphere. 2020 Jan 15;4(1):e333. doi: 10.1097/HS9.0000000000000333. eCollection 2020 Feb.

High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals.健康个体中循环记忆 T 细胞针对钙网蛋白外显子 9 突变的高频。

Blood Cancer J. 2019 Jan 17;9(2):8. doi: 10.1038/s41408-018-0166-4.

p.Y317H is a new gain-of-function mutation affecting the FERM domain in a myelofibrosis patient with mutation.p.Y317H是一种新的功能获得性突变，在一名患有该突变的骨髓纤维化患者中影响FERM结构域。

Haematologica. 2017 Aug;102(8):e328-e331. doi: 10.3324/haematol.2017.166439. Epub 2017 May 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验